While corroborating established Trop2 expression patterns in gastrointestinal cancers, our study uniquely incorporates complete clinicopathological profiling and multivariate regression to delineate how tumor composition, staging, invasion status, and molecular characteristics collectively influence Trop2 expression. Here, TACSTD2 is linked to neoplasm.